Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-15

Clinical Trial Update: TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy) [Phase 4]

View source ↗

Summary

Phase 4 study evaluating tuberculosis preventive therapy in people with HIV on HAART has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: Tuberculosis, HIV Infections | Phase 4 | Status: COMPLETED